Goodwill and Intangible Assets, Net

9 Months Ended

Sep. 30, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

The carrying values of goodwill assigned to the Company’s operating segments are as follows:


	September 30, 2022		December 31, 2021
Cell Therapy	$	112,347	$	112,347
Degenerative Disease		3,610		3,610
Biobanking		7,347		7,347
	$	123,304	$	123,304

Intangible Assets, Net

Intangible assets, net consisted of the following:


	September 30, 2022			December 31, 2021			Estimated Useful Lives
Amortizable intangible assets:
Developed technology	$	16,810		$	16,810		11-16 years
Customer relationships		2,413			2,413		10 years
Trade names & trademarks		570			570		10-13 years
Reacquired rights		4,200			4,200		6 years
		23,993			23,993
Less: Accumulated amortization
Developed technology		(6,253	)		(5,376	)
Customer relationships		(1,369	)		(1,170	)
Trade names & trademarks		(261	)		(220	)
Reacquired rights		(3,063	)		(2,540	)
		(10,946	)		(9,306	)
Amortizable intangible assets, net		13,047			14,687

Non-amortized intangible assets
Acquired IPR&D product rights		108,500			108,500		indefinite
	$	121,547		$	123,187

For the three months ended September 30, 2022 and 2021, amortization expense for intangible assets was $553 and $553, respectively. For the nine months ended September 30, 2022 and 2021, amortization expense for intangible assets was $1,640 and $1,640, respectively.

No impairment charges were recorded for the three and nine months ended September 30, 2022 and 2021.